DNA Capital is a Brazil based venture capital firm founded by Mario Sergio Ribeiro in 2013. The firm prefers to invests in companies that focuses on the healthcare sector. This firm invests in early stage ventures, last stage ventures, and seed ventures in series A and series B rounds.
As of December 2019, DNA Capital is actively looking for new investment opportunities. The firm's notable investment portfolio includes Alto Pharmacy, Arterys, Beep Saúde, Cambridge Epigenetix, Clover Health, CM Tecnologia, Feegow Clinic, OMNY, The CareVoice and uBiome.
Carlos de Barros Jorge Neto
José Eduardo Ribeiro Guinle
Luiz Felipe D Martins Costa
Luiz Henrique Noronha
Mario Sergio Ribeiro
Founding Partner & Managing Director
Documentaries, videos and podcasts